Vernal Keratoconjunctivitis Market
Vernal Keratoconjunctivitis (VKC) is a relatively rare, chronic form of ocular allergy that can potentially cause severe visual complications. Affecting mainly children and young adults, it is an IgE- and T cell-mediated disease, leading to a chronic inflammation in which eosinophil, lymphocyte and structural cell activation are involved.
- The increasing population and rising prevalence of Vernal Keratoconjunctivitis generates a large patient population in the global market. In 2017, a total of 4,752,356 patients were affected by Vernal Keratoconjunctivitis in the global market.
- China contributes the largest share among EU-5, and Japan, with 2,248,706 cases in 2017.
- The total diagnosed prevalent population of Vernal Keratoconjunctivitis was 2,943,057 in the global market.
Comments
Post a Comment